Date Field | Doc. No. | Party | Description |
---|
Dec 1, 2017 | 16 | | Notice of Refund Download |
Nov 29, 2017 | 15 | | Petitioner's Request for Refund of Post-Institution Fee Download |
Sep 7, 2017 | 14 | | Decision Denying Institution of Inter Partes Review Download |
Jun 11, 2017 | 12 | | Patent Owner's Updated Mandatory Notices Download |
Jun 11, 2017 | 13 | | Patent Owner's Preliminary Response Download |
Jun 11, 2017 | 2055 | | ZEVALIN Label Download |
Jun 11, 2017 | 2028 | | Rouet 2014 Download |
Jun 11, 2017 | 2021 | | Daugherty 2006 Download |
Jun 11, 2017 | 2047 | | Wang 2007 Download |
Jun 11, 2017 | 11 | | Patent Owner's Updated Power of Attorney Download |
Jun 11, 2017 | 2042 | | Humphreys 2015 Download |
Jun 11, 2017 | 2051 | | Shire 2015 Download |
Apr 10, 2017 | 10 | | REPLACEMENT PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. ¿¿¿¿ 311¿¿¿319 AND 37 C.F.R. ¿¿ 42 Download |
Apr 10, 2017 | 1102 | | Replacement Exhibit 1102 - Radtke Declaration Download |
Apr 10, 2017 | 1105 | | Replacement Exhibit 1105 - Humira in PDR 2004 Download |
Apr 10, 2017 | 1108 | | Replacement Exhibit 1108 - Gamimune in PDR 2002 Download |
Apr 7, 2017 | 9 | | Order Conduct of the Proceeding Download |
Mar 23, 2017 | 8 | | Petitioner's Updated Mandatory Notices Download |
Mar 17, 2017 | 7 | | Patent Owner's Second Updated Mandatory Notices Download |
Feb 27, 2017 | 6 | | Patent Owner's Updated Mandatory Notices Download |
Feb 24, 2017 | 5 | | Notice of Accord Filing Date Download |
Feb 21, 2017 | 3 | | Patent Owner's Power of Attorney Download |
Feb 21, 2017 | 4 | | Patent Owner's Mandatory Notices Download |
Jan 31, 2017 | 1113 | | AbbVie Biotechnology Ltd., ¿¿¿Annex A ¿¿¿ The Humira¿¿ Story,¿¿¿ Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download |
Jan 31, 2017 | 1108 | | GAMIMUNE¿¿ Label (Oct. 2005) Download |
Jan 31, 2017 | 1143 | | GAMMAGARD LIQUID Label (April 2005) Download |
Jan 31, 2017 | 1116 | | Gokarn et al., ¿¿¿Excipients for Protein Drugs,¿¿¿ Download |
Jan 31, 2017 | 1153 | | Akers et al., ¿¿¿Formulation Development of Protein Dosage Forms,¿¿¿ Download |
Jan 31, 2017 | 1159 | | Frenken et al., ¿¿¿Identification of the Component Part in an Epoetin Alfa Preparation that Causes Pain after Subcutaneous Injection,¿¿¿ Download |
Jan 31, 2017 | 1109 | | SYNAGIS¿¿ Label (July 2004) Download |
Jan 31, 2017 | 2 | | PETITIONER'S POWER OF ATTORNEY PURSUANT TO 37 CFR 42.lO(b) Download |
Jan 31, 2017 | 1156 | | Handbook of Pharmaceutical Excipients Download |
Jan 31, 2017 | 1104 | | U.S. App. 60/690,582 to Gokarn et al. Download |
Jan 31, 2017 | 1134 | | U.S. Pub. No. 2012/0028877 Download |
Jan 31, 2017 | 1135 | | U.S. Pub. No. 2008/0311078 Download |
Jan 31, 2017 | 1123 | | U.S. Prosecution History of App. No. 13/774,735 (Part 2) Download |
Jan 31, 2017 | 1128 | | Schwartz, ¿¿¿Diafiltration for Desalting of Buffer Exchange,¿¿¿ BioProcess Int¿¿¿l Download |
Jan 31, 2017 | 1119 | | Olthuis et al., ¿¿¿Characterization of Proteins by Means of their Buffer Capacity..." Download |
Jan 31, 2017 | 1115 | | Van Slyke, ¿¿¿On the Measurement of Buffer Values and on the..." Download |
Jan 31, 2017 | 1142 | | CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010) Download |
Jan 31, 2017 | 1107 | | Adalimumab Product Approval Information Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download |
Jan 31, 2017 | 1136 | | WO 2006/138181 Download |
Jan 31, 2017 | 1111 | | TYSABRI¿¿ Label (Nov. 2004) Download |
Jan 31, 2017 | 1122 | | U.S. Prosecution History of App. No. 14/506,576 Download |
Jan 31, 2017 | 1138 | | WO 1997/029131 Download |
Jan 31, 2017 | 1150 | | Butler & Hamilton, ¿¿¿Quantitation of Specific Antibodies: Methods of Express, Standards, Solid-Phase Considerations, and Specific Applications,¿¿¿ Download |
Jan 31, 2017 | 1152 | | McDonnell, ¿¿¿Production of Antibodies in Hybridoma and Non-hybridoma Cell Lines,¿¿¿ Download |
Jan 31, 2017 | 1158 | | Laursen et al., “Pain Perception after Subcutaneous Injections of Media Containing Different Buffers,” Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download |
Jan 31, 2017 | 1146 | | GAMUNEX¿¿ Label (Nov. 2005) Download |
Jan 31, 2017 | 1145 | | Flebogamma¿¿ Label (Jan. 2004) Download |
Jan 31, 2017 | 1117 | | Fransson & Espander-Jansson, ¿¿¿Local Tolerance of Subcutaneous Injections,¿¿¿ Download |
Jan 31, 2017 | 1133 | | U.S. Pub. No. 2013/0273066 Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download |
Jan 31, 2017 | 1 | | PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. ¿¿¿¿ 311¿¿¿319 AND 37 C.F.R. ¿¿ 42 Download |
Jan 31, 2017 | 1112 | | AbbVie Biotechnology Ltd., ¿¿¿Patent Owner¿¿¿s Preliminary Response,¿¿¿ Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download |
Jan 31, 2017 | 1144 | | OCTAGAM¿¿ Label (Mar. 2004) Download |
Jan 31, 2017 | 1137 | | U.S. Patent No. 6,090,382 Download |
Jan 31, 2017 | 1123 | | U.S. Prosecution History of App. No. 13/774,735 (Part 2) Download |
Jan 31, 2017 | 1127 | | ¿¿¿Fraunhofer Substantive Motion 3,¿¿¿ in Fraunhofer v. Gokarn, Patent Interference No. 106,057 Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download |
Jan 31, 2017 | 1132 | | Press Release Download |
Jan 31, 2017 | 1139 | | HUMIRA¿¿ Label (Nov. 2015) Download |
Jan 31, 2017 | 1118 | | Nozaki & Tanford, ¿¿¿Examination of Titration Behavior,¿¿¿ Download |
Jan 31, 2017 | 1126 | | Stoner et al., ¿¿¿Protein¿¿¿Solute Interactions Affect the Outcome..." Download |
Jan 31, 2017 | 1160 | | Gelfand, ¿¿¿Differences Between IGIV Products: Impact on Clinical Outcome,¿¿¿ Download |
Jan 31, 2017 | 1151 | | Jefferis et al., ¿¿¿Recognition Sites on Human IgG for Fc¿¿ Receptors: The Role of Glycosylation,¿¿¿ Download |
Jan 31, 2017 | 1148 | | HepaGam BTM Summary Basis for Approval (Jan. 2006) Download |
Jan 31, 2017 | 1101 | | U.S. Patent No. 9,085,619 Download |
Jan 31, 2017 | 1102 | | Declaration of Klaus-Peter Radtke, Ph.D. Download |
Jan 31, 2017 | 1131 | | Carnahan et al., ¿¿¿Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22: Characterization of In Vitro Properties,¿¿¿ Download |
Jan 31, 2017 | 1130 | | Gebhart, ¿¿¿Biotech Company Preparing Several Drugs for Takeoff,¿¿¿ Download |
Jan 31, 2017 | 1157 | | U.S. Pub. No. 2003/0138417 Download |
Jan 31, 2017 | 1103 | | U.S. Pub. No. 2016/0319011, Gokarn et al. Download |
Jan 31, 2017 | 1110 | | AVASTINTM Label (Feb. 2004) Download |
Jan 31, 2017 | 1141 | | Vivaglobin¿¿ Label (Jan. 2006) Download |
Jan 31, 2017 | 1106 | | HUMIRA¿¿ Label (Jan. 2008) Download |
Jan 31, 2017 | 1129 | | U.S. Pub. No. 2004/0033535, Boyle et al. Download |
Jan 31, 2017 | 1161 | | Campath¿¿ Label (Aug. 2006) Download |
Jan 31, 2017 | 1149 | | VectibixTM Label (Sept. 2006) Download |
Jan 31, 2017 | 1125 | | U.S. Prosecution History of App. No. 61/004,992 Download |
Jan 31, 2017 | 1120 | | Physicians¿¿¿ Desk Reference, pp. 558-59, 914-31, 805-07, 2026-28, 2295-97, 2524-25 (56th ed. 2002) Download |
Jan 31, 2017 | 1121 | | Parslow, ¿¿¿Immunoglobulins & Immunoglobulin Genes,¿¿¿ Download |
Jan 31, 2017 | 1105 | | HUMIRA¿¿ Label (Jan. 2003) Download |
Jan 31, 2017 | 1114 | | Christensen, ¿¿¿Proteins as buffers,¿¿¿ Download |
Jan 31, 2017 | 1155 | | Hanna, The IGIV-C Study Group, ¿¿¿Tolerability of a New Intravenous Immunoglobulin Preparation (IGIV) in Pediatric and Adult Patients,¿¿¿ Download |
Jan 31, 2017 | 1140 | | HUMIRA¿¿ Label (Oct. 2016) Download |
Jan 31, 2017 | 1147 | | Privigen¿¿ Label (Oct. 2016) Download |
Jan 31, 2017 | 1154 | | Cleland & Langer, ¿¿¿Formulation and Delivery of Proteins and Peptides: Design and Development Strategies,¿¿¿ Download |
Jan 31, 2017 | 1105 | | HUMIRA¿¿ Label (Jan. 2003) Download |
Jan 31, 2017 | 1102 | | Declaration of Klaus-Peter Radtke, Ph.D. Download |
Jan 31, 2017 | 1108 | | GAMIMUNE¿¿ Label (Oct. 2005) Download |
Jan 31, 2017 | 1123 | | U.S. Prosecution History of App. No. 13/774,735 (Part 1) Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 2) Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 6) Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 3) Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 4) Download |
Jan 31, 2017 | 1124 | | U.S. Prosecution History of App. No. 12/325,049 (Part 5) Download |